Literature DB >> 26491068

IFN-γ-mediated hematopoietic cell destruction in murine models of immune-mediated bone marrow failure.

Jichun Chen1, Xingmin Feng1, Marie J Desierto1, Keyvan Keyvanfar1, Neal S Young1.   

Abstract

Interferon gamma (IFN-γ) has been reported to have both negative and positive activity on hematopoietic cells, adding complexity to the interpretation of its pleiotropic functions. We examined the effects of IFN-γ on murine hematopoietic stem cells (HSCs) and progenitors in vitro and in vivo by using mouse models. IFN-γ treatment expanded bone marrow (BM) c-Kit(+)Sca1(+)Lin(-) (KSL) cell number but reduced BM KLCD150(+) and KLCD150(+)CD48(-) cells. IFN-γ-expanded KSL cells engrafted poorly when tested by competitive repopulation in vivo. KSL, KLCD150(+), and KLCD150(+)CD48(-) cells from IFN-γ-treated animals all showed significant upregulation in Fas expression. When cocultured with activated T cells in vitro, KSL and KLCD150(+) cells from IFN-γ-treated donors showed increased apoptosis relative to those from untreated animals, and infusion of activated CD8 T cells into IFN-γ-injected animals in vivo led to partial elimination of KSL cells. Exposure of BM cells or KSL cells to IFN-γ increased expression of Fas, caspases, and related proapoptotic genes and decreased expression of Ets-1 and other hematopoietic genes. In mouse models of BM failure, mice genetically deficient in IFN-γ receptor expression showed attenuation of immune-mediated marrow destruction, whereas effector lymphocytes from IFN-γ-deficient donors were much less potent in initiating BM damage. We conclude that the activity of IFN-γ on murine hematopoiesis is context dependent. IFN-γ-augmented apoptotic gene expression facilitates destruction of HSCs and progenitors in the presence of activated cytotoxic T cells, as occurs in human BM failure.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26491068      PMCID: PMC4671109          DOI: 10.1182/blood-2015-06-652453

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  74 in total

1.  Fas signaling in thyroid carcinomas is diverted from apoptosis to proliferation.

Authors:  Constantine S Mitsiades; Vassiliki Poulaki; Galinos Fanourakis; Elias Sozopoulos; Douglas McMillin; Zhaoqin Wen; Gerassimos Voutsinas; Sophia Tseleni-Balafouta; Nicholas Mitsiades
Journal:  Clin Cancer Res       Date:  2006-06-15       Impact factor: 12.531

Review 2.  Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunity.

Authors:  Jacinta Bustamante; Stéphanie Boisson-Dupuis; Laurent Abel; Jean-Laurent Casanova
Journal:  Semin Immunol       Date:  2014-10-26       Impact factor: 11.130

3.  Immune-mediated bone marrow failure in C57BL/6 mice.

Authors:  Jichun Chen; Marie J Desierto; Xingmin Feng; Angélique Biancotto; Neal S Young
Journal:  Exp Hematol       Date:  2014-12-30       Impact factor: 3.084

4.  Enrichment of hematopoietic stem cells with SLAM and LSK markers for the detection of hematopoietic stem cell function in normal and Trp53 null mice.

Authors:  Jichun Chen; Felicia M Ellison; Keyvan Keyvanfar; Stephanie O Omokaro; Marie J Desierto; Michael A Eckhaus; Neal S Young
Journal:  Exp Hematol       Date:  2008-06-17       Impact factor: 3.084

5.  SLAM-enriched hematopoietic stem cells maintain long-term repopulating capacity after lentiviral transduction using an abbreviated protocol.

Authors:  P Laje; P W Zoltick; A W Flake
Journal:  Gene Ther       Date:  2009-10-29       Impact factor: 5.250

6.  Interferon-gamma enhances factor-dependent myeloid proliferation of human CD34+ hematopoietic progenitor cells.

Authors:  C Caux; I Moreau; S Saeland; J Banchereau
Journal:  Blood       Date:  1992-05-15       Impact factor: 22.113

7.  Increased expression of Fas antigen on bone marrow CD34+ cells of patients with aplastic anaemia.

Authors:  J P Maciejewski; C Selleri; T Sato; S Anderson; N S Young
Journal:  Br J Haematol       Date:  1995-09       Impact factor: 6.998

8.  Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro.

Authors:  J Maciejewski; C Selleri; S Anderson; N S Young
Journal:  Blood       Date:  1995-06-01       Impact factor: 22.113

9.  FLIP switches Fas-mediated glucose signaling in human pancreatic beta cells from apoptosis to cell replication.

Authors:  Kathrin Maedler; Adriano Fontana; Frédéric Ris; Pavel Sergeev; Christian Toso; José Oberholzer; Roger Lehmann; Felix Bachmann; Andrea Tasinato; Giatgen A Spinas; Philippe A Halban; Marc Y Donath
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-11       Impact factor: 11.205

10.  Bystander destruction of hematopoietic progenitor and stem cells in a mouse model of infusion-induced bone marrow failure.

Authors:  Jichun Chen; Karen Lipovsky; Felicia M Ellison; Rodrigo T Calado; Neal S Young
Journal:  Blood       Date:  2004-05-27       Impact factor: 22.113

View more
  34 in total

1.  Eltrombopag maintains human hematopoietic stem and progenitor cells under inflammatory conditions mediated by IFN-γ.

Authors:  Luigi J Alvarado; Heather D Huntsman; Hai Cheng; Danielle M Townsley; Thomas Winkler; Xingmin Feng; Cynthia E Dunbar; Neal S Young; Andre Larochelle
Journal:  Blood       Date:  2019-02-25       Impact factor: 22.113

2.  miR-146a-Traf6 regulatory axis controls autoimmunity and myelopoiesis, but is dispensable for hematopoietic stem cell homeostasis and tumor suppression.

Authors:  Nathaniel Magilnick; Estefany Y Reyes; Wei-Le Wang; Steven L Vonderfecht; Jin Gohda; Jun-Ichiro Inoue; Mark P Boldin
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-07       Impact factor: 11.205

3.  PD-1 deficiency augments bone marrow failure in a minor-histocompatibility antigen mismatch lymphocyte infusion model.

Authors:  Maile K Hollinger; Valentina Giudice; Nicole A Cummings; Guillermo Rivell; Hansheng Zhang; Sachiko Kajigaya; Keyvan Keyvanfar; Jichun Chen; Xingmin Feng; Neal S Young
Journal:  Exp Hematol       Date:  2018-03-07       Impact factor: 3.084

Review 4.  The Regulatory Role of IFN-γ on the Proliferation and Differentiation of Hematopoietic Stem and Progenitor Cells.

Authors:  Yuhong Qin; Cai Zhang
Journal:  Stem Cell Rev Rep       Date:  2017-12       Impact factor: 5.739

5.  Interleukin-18 plays a dispensable role in murine and likely also human bone marrow failure.

Authors:  Zhijie Wu; Valentina Giudice; Jichun Chen; Wanling Sun; Zenghua Lin; Keyvan Keyvanfar; Nidhi Talasani; Sachiko Kajigaya; Xingmin Feng; Neal S Young
Journal:  Exp Hematol       Date:  2018-10-12       Impact factor: 3.084

Review 6.  Inflammatory bone marrow microenvironment.

Authors:  Nils B Leimkühler; Rebekka K Schneider
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

7.  Adaptive NK cells can persist in patients with GATA2 mutation depleted of stem and progenitor cells.

Authors:  Heinrich Schlums; Moonjung Jung; Hongya Han; Jakob Theorell; Venetia Bigley; Samuel C C Chiang; David S J Allan; Jan K Davidson-Moncada; Rachel E Dickinson; Tim D Holmes; Amy P Hsu; Danielle Townsley; Thomas Winkler; Weixin Wang; Pål Aukrust; Ingvild Nordøy; Katherine R Calvo; Steve M Holland; Matthew Collin; Cynthia E Dunbar; Yenan T Bryceson
Journal:  Blood       Date:  2017-02-16       Impact factor: 22.113

Review 8.  Aplastic Anemia.

Authors:  Neal S Young
Journal:  N Engl J Med       Date:  2018-10-25       Impact factor: 91.245

9.  CD8+ T cells drive autoimmune hematopoietic stem cell dysfunction and bone marrow failure.

Authors:  David M Gravano; Mufadhal Al-Kuhlani; Dan Davini; P Dominick Sanders; Jennifer O Manilay; Katrina K Hoyer
Journal:  J Autoimmun       Date:  2016-07-21       Impact factor: 7.094

10.  Macrophage TNF-α licenses donor T cells in murine bone marrow failure and can be implicated in human aplastic anemia.

Authors:  Wanling Sun; Zhijie Wu; Zenghua Lin; Maile Hollinger; Jichun Chen; Xingmin Feng; Neal S Young
Journal:  Blood       Date:  2018-10-25       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.